Filter
1763
Text search:
profiles
Featured
177
433
Language
Document type
821
344
310
90
85
43
28
17
14
6
3
2
Countries
93
59
44
35
31
30
29
28
28
28
27
27
24
23
21
21
19
18
17
17
16
16
16
16
14
14
13
13
13
13
12
12
11
10
10
10
10
9
9
9
8
8
8
8
8
7
6
6
6
6
6
5
5
5
5
5
5
4
4
4
4
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
627
172
117
107
97
23
17
Toolboxes
143
126
126
95
65
62
60
53
49
47
39
38
37
36
34
27
26
22
22
13
9
8
7
7
6
Adolescent alcohol-related behaviours: trends and inequalities in the WHO European Region, 2002–2014
Observations from the Health Behaviour in School-aged Children (HBSC) WHO collaborative cross-national study
Rapid review and case studies from Member States
SCOPING QUESTION: In the management of prescription opioid dependence, does supervised dosing with a long-acting opioid medication result in less opioid use and related harms than non-prescription, detoxification or usual care?
Amphetamine-type stimulants, new psychoactive substances
-4-
World Drug Report 2017
Accessed: 14.03.2019
New criteria for classifying and diagnosing hyperglycaemia first detected during pregnancy have been accepted by a group of experts convened by WHO. These new criteria are an update of recommendations published by WHO in 1999
A stated objective of WHO’s European Mental Health Action Plan 2013–2020 is to ensure better information and knowledge for service planning, development, monitoring and evaluation, including requesting Member States to report on the indicators in the Plan.
Progress towards achieving the int
...
The disaster and Red Cross Red Crescent response to date
9 March 2019: Tropical Cyclone Idai forms over Northern Mozambique Channel. CVM preparedness and early warning actions underway
13 March 2019: IFRC Surge Capacity is deployed to Maputo
14 March 2019: 342,562 Swiss francs allocated from th
...
The present Consolidated guidelines include a comprehensive set of WHO recommendations for the treatment and care of DR-TB, derived from these WHO guidelines documents. The consolidated guidelines include policy recommendations on treatment regimens for isoniazid-resistant TB (Hr-TB) and MDR/RR-TB,
...
Introduction
Chapter A.3
Introduction
Chapter A.4
2017 edition
Developmental disorders
Chapter C.3
Mood disorders
Chapter E.2
Anxiety disorders
Chapter F.1
2018 edition
Anxiety disorders
Chapter F.2
Other disorders
Chapter H.3
Other disorders
Chapter H.5
Other
Chapter H.4
2015 edition
